Read More 5 minute read Healthcare Industry News Anteris edges closer to FDA IDE approval for DurAVR PARADIGM trial after promising clinical data Find out how Anteris’s DurAVR transcatheter heart valve is advancing toward a global pivotal trial and what it means for the structural heart market. bySoujanya RaviNovember 3, 2025